259
Participants
Start Date
June 23, 2016
Primary Completion Date
June 1, 2019
Study Completion Date
June 1, 2019
Ergoferon
Placebo
Scientific Research Institute of Virology of Ministry of Health of Republic Uzbekistan, Tashkent
"Federal Budget Institution of Science Central Research Institute of Epidemiology of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance", Moscow
Pirogov Russian National Research Medical University, Moscow
"Federal State Budgetary Educational Institution of Higher Education Yaroslavl State Medical University of the Ministry of Healthcare of the Russian Federation", Yaroslavl
"State budgetary Health Care institution of the Arkhangelsk region Arkhangelsk Regional Pediatric Clinical Hospital named after PG Vyzhletsova", Arkhangelsk
"Federal State Budgetary Educational Institution of Higher Education Saint Petersburg State Pediatric Medical University of the Ministry of Healthcare of the Russian Federation", Saint Petersburg
"Sailnt Petersburg State Budgetary Health Care Institution City Child Hospital №22", Saint Petersburg
"Federal State Institution Scientific Research Institute of Children's Infections Federal Biomedical Agency", Saint Petersburg
The State Budget Educational institution of High Professional Training Smolensk State Medical University of Ministry of Health Care of the Russian Federation, Smolensk
"Municipal Budgetary Health Care Institution Semashko City Hospital №1 Rostov-on-Don ", Rostov-on-Don
"Federal State Budgetary Educational Institution of Higher Education Kazan Medical University of the Ministry of Healthcare of the Russian Federation", Kazan'
"Federal State Budgetary Educational Institution of Higher Education Orenburg State Medical University of the Ministry of Healthcare of the Russian Federation", Orenburg
"Federal State Budgetary Institution of Higher Professional Education Urals State Medical University of the Ministry of Healthcare of the Russian Federation", Yekaterinburg
Lead Sponsor
Materia Medica Holding
INDUSTRY